The agreement will include, among others: assessing portfolio expansion possibilities offered by the pharmaceutical market; identifying opportunities for partnerships with companies with complementary portfolio or technological platforms in order to identify potential development opportunities in line with the national and international regulations; recommendation of the best practices for the planning and expansion of the industrial processes of the company.
“The advisory services provided by the EIB experts are going to support our vision of integration in the value chain of the European pharmaceutical industry and participation in the European production of active ingredients taking into account the current strategy for limiting dependence on the Asian raw materials. Moreover, we intend to cooperate with the EIB representatives for achieving our sustainable development objectives by means of portfolio diversification and sustainable investment projects in order to redefine our future and maintain our status as the most important Romanian manufacturer of generic medicines that is of a strategic importance for the country”, said Ioan Nani, CEO of Antibiotice.
The management team of the company formulated a business plan based on the sustainable development of its operations taking into consideration that the transition towards an economy requiring the adaptation of processes and technologies to reduce the impact on the environment has become more and more pressing.
Thus, by 2030, Antibiotice aims at consolidating a well-balanced product portfolio by assimilating 100 new products by means of in-licensing and in-house research projects. This objective, together with the increase of the manufacturing capacity utilization up to 75–80%, investments in sustainable technologies and optimization of the manufacturing processes will contribute to the gradual augmentation of the turnover up to 2.5 higher by 2030 and the increase of the business profitability from EUR 10million to EUR60 million.
The EIB has been working in Romania since 1991, channeling more than €18 billion in financing for projects that further the country’s economic and financial development. The EIB is the long-term lending institution of the European Union, owned by its Member States.
(English version by Catalina Apostoiu)